• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金蛋白破坏α-突触核蛋白/多巴胺转运体的相互作用:对多巴胺诱导毒性的影响。

Parkin disrupts the alpha-synuclein/dopamine transporter interaction: consequences toward dopamine-induced toxicity.

作者信息

Moszczynska Anna, Saleh Jumana, Zhang Hongyu, Vukusic Brian, Lee Frank J S, Liu Fang

机构信息

Department of Neuroscience, Centre for Addiction and Mental Health, Clarke Division, 250 College Street, Toronto, ON M5T 1R8, Canada.

出版信息

J Mol Neurosci. 2007;32(3):217-27. doi: 10.1007/s12031-007-0037-0.

DOI:10.1007/s12031-007-0037-0
PMID:17873367
Abstract

Parkinson's disease is characterized by progressive neuronal degeneration of dopaminergic neurons in the substantia nigra. Many factors are thought to contribute to the neuronal cell death that occurs in Parkinson's disease, including alpha-synuclein-mediated toxicity. Previously, we have reported that alpha-synuclein directly couples to the carboxyl tail of the dopamine transporter (DAT) and that the alpha-synuclein/DAT protein complex formation accelerates DAT-mediated cellular dopamine (DA) uptake and DA-induced cellular apoptosis. In the present study, we report that parkin, an E2-dependent E3 protein ubiquitin ligase associated with recessive early onset Parkinson's disease, exerts a protective effect against DA-induced alpha-synuclein-dependent cell toxicity. Parkin impairs the alpha-synuclein/DAT coupling by interacting with the carboxyl-terminus of the DAT and blocks the alpha-synuclein-induced enhancement in both DAT cell surface expression and DAT-mediated DA uptake. Moreover, we have found that parkin protects against DA-induced cell toxicity in dopaminergic SK-N-SH cells. These findings will help identify the role of these proteins in the etiology and/or maintenance of Parkinson's disease.

摘要

帕金森病的特征是黑质中多巴胺能神经元进行性神经变性。许多因素被认为与帕金森病中发生的神经元细胞死亡有关,包括α-突触核蛋白介导的毒性。此前,我们报道α-突触核蛋白直接与多巴胺转运体(DAT)的羧基末端结合,且α-突触核蛋白/DAT蛋白复合物的形成加速了DAT介导的细胞多巴胺(DA)摄取和DA诱导的细胞凋亡。在本研究中,我们报道了与隐性早发性帕金森病相关的E2依赖性E3蛋白泛素连接酶帕金(parkin)对DA诱导的α-突触核蛋白依赖性细胞毒性具有保护作用。帕金通过与DAT的羧基末端相互作用来削弱α-突触核蛋白/DAT的结合,并阻断α-突触核蛋白诱导的DAT细胞表面表达增强和DAT介导的DA摄取。此外,我们发现帕金可保护多巴胺能SK-N-SH细胞免受DA诱导的细胞毒性。这些发现将有助于确定这些蛋白质在帕金森病病因和/或维持中的作用。

相似文献

1
Parkin disrupts the alpha-synuclein/dopamine transporter interaction: consequences toward dopamine-induced toxicity.帕金蛋白破坏α-突触核蛋白/多巴胺转运体的相互作用:对多巴胺诱导毒性的影响。
J Mol Neurosci. 2007;32(3):217-27. doi: 10.1007/s12031-007-0037-0.
2
Parkin increases dopamine uptake by enhancing the cell surface expression of dopamine transporter.帕金蛋白通过增强多巴胺转运体的细胞表面表达来增加多巴胺摄取。
J Biol Chem. 2004 Dec 24;279(52):54380-6. doi: 10.1074/jbc.M409282200. Epub 2004 Oct 18.
3
Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress.α-突触核蛋白对多巴胺转运体功能的调节因细胞黏附受损和氧化应激诱导而改变。
FASEB J. 2003 Nov;17(14):2151-3. doi: 10.1096/fj.03-0152fje. Epub 2003 Sep 4.
4
Disruption of the interaction of alpha-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter.α-突触核蛋白与微管相互作用的破坏增强了多巴胺转运体在细胞表面的募集。
Biochemistry. 2005 Oct 18;44(41):13612-24. doi: 10.1021/bi050402p.
5
Redistribution of DAT/α-synuclein complexes visualized by "in situ" proximity ligation assay in transgenic mice modelling early Parkinson's disease.通过“原位”邻近连接检测在模拟早期帕金森病的转基因小鼠中可视化 DAT/α-突触核蛋白复合物的重分布。
PLoS One. 2011;6(12):e27959. doi: 10.1371/journal.pone.0027959. Epub 2011 Dec 7.
6
Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein.表达截短型突变型帕金蛋白的细菌人工染色体转基因小鼠表现出年龄依赖性运动功能减退、多巴胺能神经元变性以及蛋白酶K抗性α-突触核蛋白的积累。
J Neurosci. 2009 Feb 18;29(7):1962-76. doi: 10.1523/JNEUROSCI.5351-08.2009.
7
α-Synuclein stimulates a dopamine transporter-dependent chloride current and modulates the activity of the transporter.α-突触核蛋白刺激多巴胺转运体依赖性氯离子电流,并调节转运体的活性。
J Biol Chem. 2011 Dec 23;286(51):43933-43943. doi: 10.1074/jbc.M111.241232. Epub 2011 Oct 11.
8
Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.多巴胺转运体介导的6-羟基多巴胺体外细胞毒性取决于与帕金森病相关的突变α-突触核蛋白的表达。
Neurochem Int. 2006 Apr;48(5):329-40. doi: 10.1016/j.neuint.2005.11.008. Epub 2006 Jan 6.
9
Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis.帕金蛋白可保护人类多巴胺能神经母细胞瘤细胞免受多巴胺诱导的凋亡。
Hum Mol Genet. 2004 Aug 15;13(16):1745-54. doi: 10.1093/hmg/ddh180. Epub 2004 Jun 15.
10
Unraveling correlative roles of dopamine transporter (DAT) and Parkin in Parkinson's disease (PD) - A road to discovery?解析多巴胺转运体(DAT)和 Parkin 在帕金森病(PD)中的相关作用——探索之路?
Brain Res Bull. 2020 Apr;157:169-179. doi: 10.1016/j.brainresbull.2020.02.001. Epub 2020 Feb 6.

引用本文的文献

1
The Proteomic Landscape of Parkin-Deficient and Parkin-Overexpressing Rat Nucleus Accumbens: An Insight into the Role of Parkin in Methamphetamine Use Disorder.帕金森蛋白缺陷和过表达大鼠伏隔核的蛋白质组学图谱:深入了解帕金森蛋白在甲基苯丙胺使用障碍中的作用
Biomolecules. 2025 Jul 3;15(7):958. doi: 10.3390/biom15070958.
2
Interactions of VMAT2 with CDCrel-1 and Parkin in Methamphetamine Neurotoxicity.VMAT2与CDCrel-1和Parkin在甲基苯丙胺神经毒性中的相互作用。
Int J Mol Sci. 2024 Dec 5;25(23):13070. doi: 10.3390/ijms252313070.
3
Neurotoxic Methamphetamine Doses Alter CDCel-1 Levels and Its Interaction with Vesicular Monoamine Transporter-2 in Rat Striatum.

本文引用的文献

1
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.果蝇粉色1基因是线粒体功能所必需的,并且在遗传学上与帕金蛋白相互作用。
Nature. 2006 Jun 29;441(7097):1162-6. doi: 10.1038/nature04779. Epub 2006 May 3.
2
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin.果蝇PINK1突变体中的线粒体功能障碍可被帕金蛋白弥补。
Nature. 2006 Jun 29;441(7097):1157-61. doi: 10.1038/nature04788. Epub 2006 May 3.
3
The dopamine transporter proteome.多巴胺转运体蛋白质组
神经毒性剂量的甲基苯丙胺会改变大鼠纹状体中CDCel-1的水平及其与囊泡单胺转运体-2的相互作用。
bioRxiv. 2024 Jul 23:2024.07.21.604458. doi: 10.1101/2024.07.21.604458.
4
Interplay between α-synuclein and parkin genes: Insights of Parkinson's disease.α-突触核蛋白与 parkin 基因的相互作用:帕金森病的研究进展。
Mol Biol Rep. 2024 Apr 29;51(1):586. doi: 10.1007/s11033-024-09520-7.
5
Genetic modifiers of synucleinopathies-lessons from experimental models.突触核蛋白病的基因修饰因子——来自实验模型的经验教训
Oxf Open Neurosci. 2023 Mar 9;2:kvad001. doi: 10.1093/oons/kvad001. eCollection 2023.
6
Parkin regulates drug-taking behavior in rat model of methamphetamine use disorder.Parkin 调节了 methamphetamine 使用障碍大鼠模型中的药物摄取行为。
Transl Psychiatry. 2021 May 17;11(1):293. doi: 10.1038/s41398-021-01387-7.
7
Regulation of Glutamate, GABA and Dopamine Transporter Uptake, Surface Mobility and Expression.谷氨酸、γ-氨基丁酸和多巴胺转运体摄取、表面流动性及表达的调控
Front Cell Neurosci. 2021 Apr 13;15:670346. doi: 10.3389/fncel.2021.670346. eCollection 2021.
8
Dynamic control of the dopamine transporter in neurotransmission and homeostasis.多巴胺转运体在神经传递和体内平衡中的动态调控。
NPJ Parkinsons Dis. 2021 Mar 5;7(1):22. doi: 10.1038/s41531-021-00161-2.
9
Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.异源溶质载体:功能、结构、病理学和药理学。
Adv Exp Med Biol. 2021;21:13-127. doi: 10.1007/5584_2020_584.
10
Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.多巴胺与囊泡单胺转运体的调控:药理学靶点及其对疾病的影响
Pharmacol Rev. 2015 Oct;67(4):1005-24. doi: 10.1124/pr.114.010397.
J Neurochem. 2006 Apr;97 Suppl 1:3-10. doi: 10.1111/j.1471-4159.2006.03719.x.
4
Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.多巴胺转运体介导的6-羟基多巴胺体外细胞毒性取决于与帕金森病相关的突变α-突触核蛋白的表达。
Neurochem Int. 2006 Apr;48(5):329-40. doi: 10.1016/j.neuint.2005.11.008. Epub 2006 Jan 6.
5
Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human alpha-synuclein in mice.运动性多动以及多巴胺神经传递的改变与小鼠中A53T突变型人α-突触核蛋白的过表达有关。
Neurobiol Dis. 2006 Feb;21(2):431-43. doi: 10.1016/j.nbd.2005.08.005. Epub 2005 Oct 14.
6
Dopamine covalently modifies and functionally inactivates parkin.多巴胺可共价修饰并使帕金蛋白功能失活。
Nat Med. 2005 Nov;11(11):1214-21. doi: 10.1038/nm1314. Epub 2005 Oct 16.
7
Early-onset Parkinson's disease in a Chinese population: 99mTc-TRODAT-1 SPECT, Parkin gene analysis and clinical study.中国人群早发性帕金森病:99mTc-TRODAT-1单光子发射计算机断层扫描、帕金基因分析及临床研究
Parkinsonism Relat Disord. 2005 May;11(3):173-80. doi: 10.1016/j.parkreldis.2004.12.004.
8
Parkin gene therapy for alpha-synucleinopathy: a rat model of Parkinson's disease.用于α-突触核蛋白病的帕金基因疗法:帕金森病大鼠模型
Hum Gene Ther. 2005 Feb;16(2):262-70. doi: 10.1089/hum.2005.16.262.
9
Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation.帕金介导突触核蛋白-1的非经典、蛋白酶体非依赖性泛素化:对路易小体形成的影响。
J Neurosci. 2005 Feb 23;25(8):2002-9. doi: 10.1523/JNEUROSCI.4474-04.2005.
10
Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.在帕金森病的α-突触核蛋白大鼠模型中,慢病毒载体递送帕金蛋白可预防多巴胺能神经元变性。
Proc Natl Acad Sci U S A. 2004 Dec 14;101(50):17510-5. doi: 10.1073/pnas.0405313101. Epub 2004 Dec 2.